CellScape Company
.jpg)
CellScape Corporation is focused on developing a comprehensive non-invasive prenatal genetic test for women.
Total Funding:
$21 297 167
Headquarters:
Newark, California, United States
Funding Status:
Early Stage Venture
Estimated Revenue:
Less than $1M
Last Funding Type:
Series B
Last Funding Date:
2013-05-10
Founded Date:
2008-01-01
Industry:
Pregnancy